What we have to know about corticosteroids use during Sars-Cov-2 infection
Abstract Purpose Glucocorticoids (GCs), alone or associated to other drugs, were widely
used in the management of patients affected by severe acute respiratory syndrome caused …
used in the management of patients affected by severe acute respiratory syndrome caused …
COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency?
C Scaroni, M Armigliato, S Cannavò - Journal of endocrinological …, 2020 - Springer
In critically ill patients affected by severe acute respiratory syndrome caused by Sars-Cov-2
infection, steroids, usually methylprednisolone, are currently administered despite data on …
infection, steroids, usually methylprednisolone, are currently administered despite data on …
Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess
F Vogel, M Reincke - Reviews in Endocrine and Metabolic Disorders, 2022 - Springer
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side
effects, including an increased risk of infections. Via both mechanism, immune impairments …
effects, including an increased risk of infections. Via both mechanism, immune impairments …
COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders
Abstract Purpose Coronavirus disease-19 (COVID-19) has spread throughout the world. It
was initially defined as a potentially severe syndrome affecting the respiratory tract, but it has …
was initially defined as a potentially severe syndrome affecting the respiratory tract, but it has …
The relationship between COVID-19 and hypothalamic–pituitary–adrenal axis: a large spectrum from glucocorticoid insufficiency to excess—the CAPISCO …
M Jensterle, R Herman, A Janež, WA Mahmeed… - International Journal of …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a highly heterogeneous disease regarding
severity, vulnerability to infection due to comorbidities, and treatment approaches. The …
severity, vulnerability to infection due to comorbidities, and treatment approaches. The …
[HTML][HTML] Adrenal insufficiency and glucocorticoid use during the COVID-19 pandemic
MQ Almeida, BB Mendonca - Clinics, 2020 - SciELO Brasil
The coronavirus disease 2019 (COVID-19) is an emerging pandemic challenge. Acute
respiratory distress syndrome (ARDS) in COVID-19 is characterized by a severe cytokine …
respiratory distress syndrome (ARDS) in COVID-19 is characterized by a severe cytokine …
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view
AM Berton, N Prencipe, R Giordano, E Ghigo… - Journal of …, 2021 - Springer
Systemic corticosteroids are not currently recommended for the treatment of lung injury
related to the Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2) infection …
related to the Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2) infection …
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency
AM Isidori, G Arnaldi, M Boscaro, A Falorni… - Journal of …, 2020 - Springer
In November 2019, the Italian Society of Endocrinology (SIE) has published a consensus
statement on the tailoring of glucocorticoid replacement in adrenal insufficiency [1]. A few …
statement on the tailoring of glucocorticoid replacement in adrenal insufficiency [1]. A few …
Glucocorticoid excess and COVID-19 disease
V Guarnotta, R Ferrigno, M Martino, M Barbot… - Reviews in Endocrine …, 2020 - Springer
The pandemic of coronavirus disease (COVID-19), a disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing high and rapid morbidity and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing high and rapid morbidity and …
Adrenal function in relation to cytokines and outcome in non-critically ill patients with COVID-19
N Athanasiou, A Diamantopoulos, C Keskinidou… - Journal of …, 2024 - Springer
Purpose We aimed to identify whether hypothalamic–pituitary–adrenal (HPA) axis
dysfunction is related to deterioration in a percentage of patients who progress to severe …
dysfunction is related to deterioration in a percentage of patients who progress to severe …